Wilsons has given its verdict on these big names and it's good. The post Why Cochlear and ResMed shares could be strong buys ...
Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...
Many of the major healthcare stocks on the ASX are looking cheap, Wilsons Advisory says, with some offering great value at ...
The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a ...
Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...
Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa® System - the world's first and only smart cochlear implant system. The new Cochlear™ Nucleus® ...
Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, 18-month-old Nene Gudavadze is responding to sound, dancing to music, and ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants for children ages 7 months and older with bilateral sensorineural hearing ...
Ben Summers lights up with a smile the moment he talks about the “Batman” theme song or the afternoons he spends playing the piano at his grandmother’s house. Just a few years ago, Ben could not hear ...
Ray Cathey is on a journey from silence to new sounds. Cathey's hearing took a pounding when he was an air rescue paramedic during the Vietnam War. "When you're in helicopters all the time and you've ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...